サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439199

生化学自動診断の世界市場の評価：コンポーネント別、器具タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Biochemical Auto-Diagnostics Market Assessment, By Component, By Instrument Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 233 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.36円
生化学自動診断の世界市場の評価：コンポーネント別、器具タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）
出版日: 2024年02月28日
発行: Market Xcel - Markets and Data
ページ情報: 英文 233 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生化学自動診断の市場規模は、2023年の50億1,000万米ドルから2031年に78億1,000万米ドルに達し、予測期間の2024年～2031年にCAGRで5.7％の成長が見込まれています。主に迅速かつ正確な診断検査に対する需要の高まりが、市場を牽引しています。検査処置の自動化や、疾患の早期診断の重視、生化学診断に使用される技術の進歩は、その他の成長促進要因として作用しています。慢性疾患や感染症による疾病負担の急増は、自動化された診断処置に対する需要を大幅に高め、この市場の範囲をさらに拡大しています。疾病にかかりやすい老年人口の増加も、診断に対する需要を高めています。診断技術の拡大に対する関係当局からの規制支援は、市場の成長をさらに後押しします。

しかし、生化学自動分析装置の購入や運用にかかるコストが高いため、検査室にとっての保有のしやすさが問題となり、これがメーカーにとっての大きな課題の1つとなっています。また、新技術を採用することへの抵抗や適切なトレーニングモジュールの不足も大きな課題となりますが、各社は現在これに取り組んでいます。

2023年6月、Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（Mindray）は、高スループットのM1000 Chemistry and Immunoassay Integrated Solutionを発売しました。このソリューションにはBS-2800M Chemistry Analyzer、CL-8000i Chemiluminescence Immunoassay Analyzer、インテリジェントサンプルデリバリーモジュールが含まれます。

迅速かつ正確な診断検査に対する需要の高まり

迅速かつ正確な診断検査に対する需要の高まりは、非伝染性疾患の流行、高齢化、即時の医療診断、スクリーニング、調査へのニーズなどの要因によってもたらされています。診断検査に対する需要は、慢性疾患の有病率の増加と高齢化により増加し続けています。即時の医療診断と調査の必要性が高まるにつれて、先進の分析装置と革新的な技術への需要は高まります。このため、臨床化学分析装置の技術革新が進み、疾病の早期発見とより大規模な検査が可能になっています。診断に対する需要の高まりは、自動診断生化学分析装置および消耗品によって容易に対応でき、市場はさらに拡大しています。メーカー各社は、迅速で精密な生化学分析装置に向けソリューションの生産に積極的に取り組んでいます。

例えば、2023年5月、Beckman CoulterはDxI 9000 Access Immunoassay Analyzerを発表しました。DxI 9000 Analyzerは1平方メートルあたり毎時最大215件の検査が可能で、設置面積の点でもっとも生産性の高いイムノアッセイ分析装置です。Beckman Coulterは、先進の診断ソリューションを世界中に提供する主要プロバイダーです。

検査処置の急速な自動化

検査処置の急速な自動化により、生化学自動分析装置の需要が高まっています。診断検査室の自動化が進むにつれて、精巧な装置は数百から数千の検査をこなすことができるようになっています。そのため、自動化された分析装置の需要が高まっています。自動化は迅速でコスト効率に優れた高品質の検査をもたらし、このことは臨床検査室における検体量の増加とオペレーショナルエクセレンスへのニーズを満たすのに不可欠です。また、自動化は何十年もの間、ほとんどの臨床化学ワークフローに不可欠な要素であり、検査室が多くの検査依頼を処理し、コストを削減することを可能にしてきました。

2023年7月、Siemens Healthineersは米国FDAに承認された免疫測定診断向けAtellica CI Analyserを発売しました。Atellica CI Analyserは、スタンドアロンラボやサテライトラボがAtellica Solutionと同じ試薬、消耗品、インテリジェントソフトウェアにアクセスすることを可能にします。この技術は1.9平方メートルの小さなスペースに収まるように設計されており、スペースの限られたラボに最適です。ランダムアクセスサンプリング、微量吸引、メンテナンスと品質管理の自動スケジューリングを可能にすることにより、ラボはより信頼性の高いタイムリーな結果を提供することができます。

当レポートでは、世界の生化学自動診断市場について調査分析し、市場規模と予測、市場力学、主要企業の情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の生化学自動診断市場の見通し（2017年～2031年）

  • 市場規模と予測
    • 金額
    • 数量
  • コンポーネント別
    • 器具
    • 試薬
    • 消耗品
  • 器具タイプ別
    • 全自動生化学分析装置
    • 半自動生化学分析装置
  • 用途別
    • 臨床診断
    • バイオリアクター副生成物検出
    • 医薬品開発用途
    • その他
  • エンドユーザー別
    • 病院
    • 診断センター
    • 製薬企業、バイオテクノロジー企業
    • 学術研究機関
    • 開発業務受託機関
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • 南米
    • 中東・アフリカ
  • 市場シェア：企業別（2023年）

第5章 世界の生化学自動診断市場の見通し：地域別（2017年～2031年）

  • 北米
    • 市場規模と予測
    • コンポーネント別
    • 器具タイプ別
    • 用途別
    • エンドユーザー別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • トルコ
    • ロシア
    • オランダ
    • ポーランド
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • ベトナム
    • インドネシア
    • フィリピン
  • 南米
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第6章 市場マッピング（2023年）

  • コンポーネント別
  • 器具タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

  • 特許情勢
  • 規制当局の承認
  • イノベーション/新技術

第10章 主要企業の情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析（2023年）
  • 合併と買収/合弁事業（該当する場合）
  • SWOT分析（市場参入企業5社）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

  • Roche Diagnostics GmbH
  • Sysmex Corporation
  • Sartorius AG
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • Siemens AG
  • Beckman Coulter Inc.
  • Abbott Diagnostics Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Hologic, Inc.

第14章 戦略的推奨事項

第15章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 4. Global Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 5. Global Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 6. Global Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 7. Global Biochemical Auto-Diagnostics Market Share (%), By Region, 2017-2031F
  • Figure 8. North America Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 9. North America Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 10. North America Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 11. North America Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 12. North America Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 13. North America Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 14. North America Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 15. United States Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. United States Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 17. United States Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 18. United States Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 19. United States Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 20. United States Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 21. Canada Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 22. Canada Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 23. Canada Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 24. Canada Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 25. Canada Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 26. Canada Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 27. Mexico Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28. Mexico Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 29. Mexico Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 30. Mexico Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 31. Mexico Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 32. Mexico Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 34. Europe Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 35. Europe Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 36. Europe Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 37. Europe Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 38. Europe Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 39. Europe Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 40. Germany Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. Germany Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 42. Germany Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 43. Germany Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 44. Germany Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 45. Germany Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 46. France Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. France Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. France Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 49. France Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 50. France Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 51. France Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 52. Italy Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Italy Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 54. Italy Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 55. Italy Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 56. Italy Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 57. Italy Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 58. United Kingdom Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 59. United Kingdom Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 60. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 61. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 62. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 63. United Kingdom Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 64. Russia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Russia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 66. Russia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 67. Russia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 68. Russia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 69. Russia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 70. Netherlands Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 71. Netherlands Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 72. Netherlands Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 73. Netherlands Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 74. Netherlands Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 75. Netherlands Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 76. Spain Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77. Spain Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 78. Spain Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 79. Spain Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 80. Spain Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 81. Spain Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 82. Turkey Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. Turkey Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 84. Turkey Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 85. Turkey Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 86. Turkey Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 87. Turkey Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 88. Poland Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Poland Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Poland Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 91. Poland Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 92. Poland Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 93. Poland Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 94. South America Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. South America Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 96. South America Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 97. South America Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 98. South America Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 99. South America Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 100. South America Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 101. Brazil Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. Brazil Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 103. Brazil Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 104. Brazil Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 105. Brazil Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 106. Brazil Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 107. Argentina Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 108. Argentina Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 109. Argentina Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 110. Argentina Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 111. Argentina Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 112. Argentina Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 113. Asia-Pacific Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 114. Asia-Pacific Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 115. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 116. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 117. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 118. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 119. Asia-Pacific Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 120. India Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 121. India Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 122. India Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 123. India Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 124. India Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 125. India Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 126. China Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. China Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 128. China Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 129. China Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 130. China Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 131. China Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 132. Japan Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 133. Japan Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 134. Japan Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 135. Japan Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 136. Japan Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 137. Japan Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 138. Australia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 139. Australia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 140. Australia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 141. Australia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 142. Australia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 143. Australia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 144. Vietnam Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 145. Vietnam Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 146. Vietnam Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 147. Vietnam Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 148. Vietnam Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 149. Vietnam Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 150. South Korea Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151. South Korea Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 152. South Korea Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 153. South Korea Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 154. South Korea Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 155. South Korea Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 156. Indonesia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 157. Indonesia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 158. Indonesia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 159. Indonesia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 160. Indonesia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 161. Indonesia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 162. Philippines Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 163. Philippines Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 164. Philippines Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 165. Philippines Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 166. Philippines Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 167. Philippines Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 168. Middle East & Africa Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 169. Middle East & Africa Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 170. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 171. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 172. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 173. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 174. Middle East & Africa Biochemical Auto-Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 175. Saudi Arabia Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176. Saudi Arabia Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 177. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 178. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 179. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 180. Saudi Arabia Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 181. UAE Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. UAE Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. UAE Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 184. UAE Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 185. UAE Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 186. UAE Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 187. South Africa Biochemical Auto-Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 188. South Africa Biochemical Auto-Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 189. South Africa Biochemical Auto-Diagnostics Market Share (%), By Component, 2017-2031F
  • Figure 190. South Africa Biochemical Auto-Diagnostics Market Share (%), By Instrument Type, 2017-2031F
  • Figure 191. South Africa Biochemical Auto-Diagnostics Market Share (%), By Application, 2017-2031F
  • Figure 192. South Africa Biochemical Auto-Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 193. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194. By Instrument Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11035

Global biochemical auto-diagnostics market is projected to witness a CAGR of 5.7% during the forecast period 2024-2031, growing from USD 5.01 billion in 2023 to USD 7.81 billion in 2031. The growing demand for rapid and accurate diagnostic tests primarily drives the biochemical auto-diagnostics market. Automation of laboratory procedures, emphasis on early diagnosis of diseases, and advancements in technologies used for biochemistry diagnostics are acting as other growth-inducing factors. The rapidly growing disease burden of chronic and infectious diseases significantly raises the demand for automated diagnostics procedures, further expanding the scope of this market. The growing geriatric population, which is most prone to catching diseases, increases the demand for diagnostics. Regulatory support from concerned authorities for technology expansion in diagnostics further boosts the market growth.

However, the high cost of purchasing and operating the automated biochemistry analyzer raises affordability issues for laboratories, which is one of the major challenges for the manufacturers. A significant challenge also comes from resistance to adopting new technology and a lack of suitable training modules, although companies are working on this now.

In June 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray) launched the high-throughput M1000 Chemistry and Immunoassay Integrated Solution. The solution includes the BS-2800M Chemistry Analyzer, CL-8000i Chemiluminescence Immunoassay Analyzer, and an intelligent sample delivery module.

Growing Demand for Rapid and Accurate Diagnostic Tests

The growing demand for rapid and accurate diagnostic tests is driven by factors such as the rising prevalence of noncommunicable diseases, an aging population, and the need for immediate medical diagnosis, screening, and surveillance. The demand for diagnostic testing continues to rise due to the increasing prevalence of chronic conditions and the aging population. As the need for immediate medical diagnosis and surveillance increases, the demand for advanced analyzers and innovative technologies rises. This has led to technological innovations in clinical chemistry analyzers, enabling early disease detection and testing on a larger scale. The growing demand for diagnostics can be easily catered to through auto-diagnostics biochemistry analyzers and consumables, further expanding the market. Manufacturers are actively involved in producing solutions for rapid and precise biochemistry analyzers.

For instance, in May 2023, Beckman Coulter unveiled the DxI 9000 Access Immunoassay Analyzer. The DxI 9000 Analyzer can perform up to 215 tests per hour per square meter, making it the most productive immunoassay analyzer in terms of footprint. Beckman Coulter is a leading provider of advanced diagnostics solutions across the globe.

Rapid Automation of Laboratory Procedures

The rapid automation of laboratory procedures has increased the demand for automated biochemistry analyzers. As diagnostic laboratories become more automated, sophisticated instruments can complete hundreds to thousands of tests. This has led to an increased demand for automated analyzers. Automation allows for fast, cost-efficient, and high-quality testing, essential to meet the growing sample load and the need for operational excellence in clinical laboratories. Additionally, automation has been an integral part of most clinical chemistry workflows for decades, allowing labs to handle many test requests and reduce costs.

In July 2023, Siemens Healthineers launched a US-FDA-approved Atellica CI Analyser for immunoassay diagnostics. The Atellica CI Analyzer allows standalone and satellite labs to access the same reagents, consumables, and intelligent software as Atellica Solution. This technology has been designed to fit into a small 1.9m2 space, perfect for laboratories with limited space. It allows labs to provide more reliable and timely results by allowing random access sampling, micro-volume aspiration, and automatic scheduling of maintenance and quality control.

Dominance of Fully Automatic Biochemistry Analyzers Segment

Fully automatic biochemistry analyzers are preferred over semi-automatic ones for several reasons. One of the primary advantages is that fully automatic analyzers require little or no manual intervention, reducing the potential for human error. They can also handle a higher throughput of samples, making them more suitable for larger laboratories with high testing volumes. Additionally, fully automatic analyzers offer more automation, from sample addition to result reporting, leading to improved efficiency and streamlined testing processes. Furthermore, the test results of fully automatic analyzers are generally more accurate and convenient than semi-automatic analyzers. Fully automatic analyzers are ideal for high sample volumes and efficient processing, semi-automatic analyzers may be sufficient for smaller laboratories or point-of-care settings with lower sample volumes and can accommodate a slightly longer turnaround time.

In July 2023, Anbio launched a fully automated CLIA analyzer. The Anbio ADL i1910 is an affordable and compact chemiluminescence immunoassay analyzer that provides a comprehensive range of testing options for analytes in human serum, plasma, whole blood, and urine samples. It uses the direct chemiluminescence method to ensure accurate and reliable hormone detection, disease screening, and antigen analysis results.

Hospitals to Lead the End-user Segment

Hospitals use biochemical analyzers for various purposes, including routine check-ups, disease screening, confirmation tests, and diagnosis of different ailments. These analyzers are critical for assessing chemicals in biological samples, analyzing analytes such as proteins, electrolytes, enzymes, and metabolites, and evaluating the performance of organs like the liver, heart, and kidneys. They are also helpful in drug monitoring, detecting drug misuse, and diagnosing infectious diseases. The growing demand for diagnostic testing has led to an increase in the usage of biochemical analyzers, making hospitals one of the primary consumers of these devices. Market players are designing products to cater to the specific requirements of hospitals.

In May 2023, Wondfo launched the Ucare-6000 Automatic Blood Gas Biochemical Analyzer at the 20th China Association of Clinical Laboratory Practice Expo (CACLP). The Ucare-6000 automatic blood gas biochemical analyzer offers accuracy, efficiency, flexibility, and simplified operation. It uses electrochemistry sensing technology, microfluidic technology, and thin-film microelectrode technology. With its sound QC system, it can perform automatic calibration and internal QC to ensure accurate results.

North America to be the Dominating Region

North America is the leading consumer of biochemistry analyzers due to the rising prevalence of chronic diseases, such as diabetes and cardiovascular disorders, which require efficient diagnostic tools to manage and monitor these conditions. The need for rapid and on-site diagnostic solutions is also driving the demand for biochemistry analyzers, and the trend toward miniaturization is contributing to cost-effectiveness. The United States is a significant market for biochemistry analyzers, with high investments in research and development initiatives. The presence of key market players like Beckman Coulter Inc., and Abbott Diagnostics Inc. in the region also contributed to the region's dominance in this market.

Future Market Scenario (2024 - 2031F)

The major drivers of the market include digital transformation for labs, increasing research and development activities across the healthcare industry, and growing expenditure on the diagnostics industry.

The growing affinity of healthcare providers for adopting technology-based solutions for diagnostics is anticipated to increase the demand for the biochemical auto-diagnostics market.

Fully automated biochemical analyzers are preferred over semi-automated biochemical analyzers due to enhanced efficacy and efficiency and are expected to be the dominating segment throughout the assessment period.

Hospitals are anticipated to be the leading end-users for this market due to the growing requirement for rapid diagnostic tests, owing to the high disease burden and growing geriatric population.

Key Players Landscape and Outlook

The key players in the landscape of the biochemical auto-diagnostics market include companies involved in the manufacturing and distribution of biochemistry analyzers and biochemical diagnostic instruments. Some prominent companies in this market are Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., and Abbott Diagnostics. These companies are known for their advanced healthcare technologies and have a significant market presence. The market is expected to witness healthy competition with the integration of new technologies.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. announced the acquisition of a 75% stake in Germany-based DiaSys Diagnostic Systems GmbH, this acquisition makes DiaSys, a subsidiary of Mindray. The acquisition will expand the IVD offerings of Mindray including the biochemical analyzers.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Biochemical Auto-Diagnostics Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Component
    • 4.2.1. Instruments
    • 4.2.2. Reagents
    • 4.2.3. Consumables
  • 4.3. By Instrument Type
    • 4.3.1. Fully Automatic Biochemistry Analyzers
    • 4.3.2. Semi-Automatic Biochemistry Analyzers
  • 4.4. By Application
    • 4.4.1. Clinical Diagnostics
    • 4.4.2. Bioreactor Byproduct Detection
    • 4.4.3. Drug Development Applications
    • 4.4.4. Others
  • 4.5. By End-user
    • 4.5.1. Hospitals
    • 4.5.2. Diagnostic Centers
    • 4.5.3. Pharmaceutical and Biotechnology Companies
    • 4.5.4. Academic Research Institutes
    • 4.5.5. Contract Research Organizations
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global Biochemical Auto-Diagnostics Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Component
      • 5.1.2.1. Instruments
      • 5.1.2.2. Reagents
      • 5.1.2.3. Consumables
    • 5.1.3. By Instrument Type
      • 5.1.3.1. Fully Automatic Biochemistry Analyzers
      • 5.1.3.2. Semi-Automatic Biochemistry Analyzers
    • 5.1.4. By Application
      • 5.1.4.1. Clinical Diagnostics
      • 5.1.4.2. Bioreactor Byproduct Detection
      • 5.1.4.3. Drug Development Applications
      • 5.1.4.4. Others
    • 5.1.5. By End-user
      • 5.1.5.1. Hospitals
      • 5.1.5.2. Diagnostic Centers
      • 5.1.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.5.4. Academic Research Institutes
      • 5.1.5.5. Contract Research Organizations
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
      • 5.1.6.1.1. By Value
      • 5.1.6.1.2. By Volume
      • 5.1.6.2. By Component
      • 5.1.6.2.1. Instruments
      • 5.1.6.2.2. Reagents
      • 5.1.6.2.3. Consumables
      • 5.1.6.3. By Instrument Type
      • 5.1.6.3.1. Fully Automatic Biochemistry Analyzers
      • 5.1.6.3.2. Semi-Automatic Biochemistry Analyzers
      • 5.1.6.4. By Application
      • 5.1.6.4.1. Clinical Diagnostics
      • 5.1.6.4.2. Bioreactor Byproduct Detection
      • 5.1.6.4.3. Drug Development Applications
      • 5.1.6.4.4. Others
      • 5.1.6.5. By End-user
      • 5.1.6.5.1. Hospitals
      • 5.1.6.5.2. Diagnostic Centers
      • 5.1.6.5.3. Pharmaceutical and Biotechnology Companies
      • 5.1.6.5.4. Academic Research Institutes
      • 5.1.6.5.5. Contract Research Organizations
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. United Kingdom
    • 5.2.4. Italy
    • 5.2.5. Spain
    • 5.2.6. Turkey
    • 5.2.7. Russia
    • 5.2.8. Netherlands
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Australia
    • 5.3.6. Vietnam
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Component
  • 6.2. By Instrument Type
  • 6.3. By Application
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Import Export Analysis
  • 7.3. Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Roche Diagnostics GmbH
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Sysmex Corporation
  • 13.3. Sartorius AG
  • 13.4. Merck KGaA
  • 13.5. Thermo Fisher Scientific Inc.
  • 13.6. Siemens AG
  • 13.7. Beckman Coulter Inc.
  • 13.8. Abbott Diagnostics Inc.
  • 13.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 13.10. Hologic, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer